List of Tables
    Table 1. Antimycobacterial Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Antimycobacterial Drugs Market Trends
    Table 3. Antimycobacterial Drugs Market Drivers
    Table 4. Antimycobacterial Drugs Market Challenges
    Table 5. Antimycobacterial Drugs Market Restraints
    Table 6. Global Antimycobacterial Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Antimycobacterial Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Antimycobacterial Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Antimycobacterial Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Antimycobacterial Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Antimycobacterial Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Antimycobacterial Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Antimycobacterial Drugs Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Antimycobacterial Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Antimycobacterial Drugs Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Antimycobacterial Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Antimycobacterial Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antimycobacterial Drugs as of 2021)
    Table 18. Top Players of Antimycobacterial Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Antimycobacterial Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Antimycobacterial Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Antimycobacterial Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Antimycobacterial Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Antimycobacterial Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Antimycobacterial Drugs Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Antimycobacterial Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Antimycobacterial Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Antimycobacterial Drugs Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Antimycobacterial Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Antimycobacterial Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Antimycobacterial Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Antimycobacterial Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Antimycobacterial Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Antimycobacterial Drugs Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Antimycobacterial Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Antimycobacterial Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Antimycobacterial Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Antimycobacterial Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Antimycobacterial Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Antimycobacterial Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Antimycobacterial Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Pfizer Corporation Information
    Table 43. Pfizer Description and Business Overview
    Table 44. Pfizer Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Pfizer Antimycobacterial Drugs Product
    Table 46. Pfizer Recent Development
    Table 47. Novartis Corporation Information
    Table 48. Novartis Description and Business Overview
    Table 49. Novartis Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Novartis Product
    Table 51. Novartis Recent Development
    Table 52. GlaxoSmithKline Corporation Information
    Table 53. GlaxoSmithKline Description and Business Overview
    Table 54. GlaxoSmithKline Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. GlaxoSmithKline Product
    Table 56. GlaxoSmithKline Recent Development
    Table 57. Bayer Corporation Information
    Table 58. Bayer Description and Business Overview
    Table 59. Bayer Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Bayer Product
    Table 61. Bayer Recent Development
    Table 62. AstraZeneca Corporation Information
    Table 63. AstraZeneca Description and Business Overview
    Table 64. AstraZeneca Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. AstraZeneca Product
    Table 66. AstraZeneca Recent Development
    Table 67. Sanofi Corporation Information
    Table 68. Sanofi Description and Business Overview
    Table 69. Sanofi Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Sanofi Product
    Table 71. Sanofi Recent Development
    Table 72. Merck Corporation Information
    Table 73. Merck Description and Business Overview
    Table 74. Merck Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Merck Product
    Table 76. Merck Recent Development
    Table 77. Lupin Corporation Information
    Table 78. Lupin Description and Business Overview
    Table 79. Lupin Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Lupin Product
    Table 81. Lupin Recent Development
    Table 82. Macleods Pharmaceuticals Corporation Information
    Table 83. Macleods Pharmaceuticals Description and Business Overview
    Table 84. Macleods Pharmaceuticals Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Macleods Pharmaceuticals Product
    Table 86. Macleods Pharmaceuticals Recent Development
    Table 87. Systopic Laboratories Corporation Information
    Table 88. Systopic Laboratories Description and Business Overview
    Table 89. Systopic Laboratories Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. Systopic Laboratories Product
    Table 91. Systopic Laboratories Recent Development
    Table 92. Zydus Cadila Corporation Information
    Table 93. Zydus Cadila Description and Business Overview
    Table 94. Zydus Cadila Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 95. Zydus Cadila Product
    Table 96. Zydus Cadila Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Antimycobacterial Drugs Customers List
    Table 100. Antimycobacterial Drugs Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Antimycobacterial Drugs Product Picture
    Figure 2. Global Antimycobacterial Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Antimycobacterial Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Antimycobacterial Drugs Sales 2017-2028 (K Units)
    Figure 5. United States Antimycobacterial Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Antimycobacterial Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Antimycobacterial Drugs Sales 2017-2028 (K Units)
    Figure 8. United States Antimycobacterial Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Antimycobacterial Drugs Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Antimycobacterial Drugs Report Years Considered
    Figure 11. Product Picture of Drugs Used for Tuberculosis
    Figure 12. Product Picture of Drugs Used for Leprosy
    Figure 13. Product Picture of Drugs Used for Atypical Mycobacteria
    Figure 14. Global Antimycobacterial Drugs Market Share by Type in 2022 & 2028
    Figure 15. Global Antimycobacterial Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Antimycobacterial Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Antimycobacterial Drugs Sales by Type (2017-2028) & (K Units)
    Figure 18. Global Antimycobacterial Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Antimycobacterial Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 20. United States Antimycobacterial Drugs Market Share by Type in 2022 & 2028
    Figure 21. United States Antimycobacterial Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Antimycobacterial Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Antimycobacterial Drugs Sales by Type (2017-2028) & (K Units)
    Figure 24. United States Antimycobacterial Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Antimycobacterial Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 26. Product Picture of Hospital Pharmacies
    Figure 27. Product Picture of Retail Pharmacies
    Figure 28. Product Picture of Online Pharmacies
    Figure 29. Global Antimycobacterial Drugs Market Share by Application in 2022 & 2028
    Figure 30. Global Antimycobacterial Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Antimycobacterial Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Antimycobacterial Drugs Sales by Application (2017-2028) & (K Units)
    Figure 33. Global Antimycobacterial Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Antimycobacterial Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 35. United States Antimycobacterial Drugs Market Share by Application in 2022 & 2028
    Figure 36. United States Antimycobacterial Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Antimycobacterial Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Antimycobacterial Drugs Sales by Application (2017-2028) & (K Units)
    Figure 39. United States Antimycobacterial Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Antimycobacterial Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 41. North America Antimycobacterial Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 42. North America Antimycobacterial Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Antimycobacterial Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Antimycobacterial Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Antimycobacterial Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 46. Europe Antimycobacterial Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Antimycobacterial Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Antimycobacterial Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Antimycobacterial Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Antimycobacterial Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Antimycobacterial Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Antimycobacterial Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 53. Asia-Pacific Antimycobacterial Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Antimycobacterial Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Antimycobacterial Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Antimycobacterial Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Antimycobacterial Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Antimycobacterial Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan Antimycobacterial Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Antimycobacterial Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Antimycobacterial Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Antimycobacterial Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Philippines Antimycobacterial Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Antimycobacterial Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 65. Latin America Antimycobacterial Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Antimycobacterial Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Antimycobacterial Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Antimycobacterial Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Antimycobacterial Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 70. Middle East & Africa Antimycobacterial Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Antimycobacterial Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Antimycobacterial Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. UAE Antimycobacterial Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Antimycobacterial Drugs Value Chain
    Figure 75. Antimycobacterial Drugs Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed